KOO vs. INS, RENX, COG, INHC, FDBK, TRLS, IQAI, DVRG, SENS, and EMIS
Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.
Kooth vs.
Instem (LON:INS) and Kooth (LON:KOO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.
Instem received 79 more outperform votes than Kooth when rated by MarketBeat users. However, 93.33% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.
In the previous week, Kooth had 11 more articles in the media than Instem. MarketBeat recorded 12 mentions for Kooth and 1 mentions for Instem. Instem's average media sentiment score of 1.36 beat Kooth's score of 0.18 indicating that Instem is being referred to more favorably in the media.
Instem has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Kooth has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Kooth has lower revenue, but higher earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.
Kooth has a consensus target price of GBX 456.67, suggesting a potential upside of 206.73%. Given Kooth's stronger consensus rating and higher possible upside, analysts clearly believe Kooth is more favorable than Instem.
Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 18.59% beat Instem's return on equity.
65.9% of Instem shares are held by institutional investors. Comparatively, 65.0% of Kooth shares are held by institutional investors. 30.0% of Instem shares are held by company insiders. Comparatively, 17.3% of Kooth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Kooth beats Instem on 11 of the 17 factors compared between the two stocks.
Get Kooth News Delivered to You Automatically
Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:KOO) was last updated on 4/20/2025 by MarketBeat.com Staff
